Allergy and Immunology · Boise, ID
NPI
1679569149
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
901 N Curtis Rd, Ste 100
Boise, ID, 83706
Phone (208) 378-0080
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
6,573 services
Medicare patients, 2024
178
Average age 72
Drug cost, 2024
$3.0M
1,689 prescriptions
Company payments, 2025
$1,501
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael V Keiley was code 95004 (test - miscellaneous), 1,506 times for 42 patients. In total Michael V Keiley billed 6,573 services in 28 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,506 | 42 | $2.40 | $3,616 |
| 95165 Treatment - Miscellaneous | Office | 585 | 36 | $8.17 | $4,778 |
| 95117 Treatment - Miscellaneous | Office | 329 | 29 | $7.03 | $2,312 |
| 95115 Treatment - Miscellaneous | Office | 249 | 13 | $6.14 | $1,529 |
| 99213 Office E&M - Established | Office | 106 | 86 | $53.04 | $5,623 |
| 96372 Injection Administration | Office | 79 | 31 | $9.89 | $781 |
| 96160 E&M - Miscellaneous | Office | 77 | 54 | $1.89 | $146 |
| 94010 Pulmonary Function Testing | Office | 69 | 62 | $17.37 | $1,198 |
| 95012 Pulmonary | Office | 57 | 52 | $11.87 | $676 |
| 99204 Office E&M - New | Office | 48 | 48 | $98.52 | $4,729 |
| 99212 Office E&M - Established | Office | 44 | 24 | $36.85 | $1,621 |
By year: 2022 $152K for 5,984 services; 2023 $160K for 6,699 services; 2024 $151K for 6,573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael V Keiley prescribed most often to Medicare patients was Ipratropium Bromide, with 296 prescriptions and refills. In total Michael V Keiley wrote 1,689 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 296 | 323 | 87 | $8,570 |
| Montelukast Sodium Generic | 182 | 302 | 46 | $1,058 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 148 | 167 | 27 | $107K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 89 | 98 | 40 | $2,068 |
| Fluticasone Propionate Generic | 83 | 142 | 40 | $1,654 |
| Dupixent Pen Dupilumab | 58 | 58 | Under 11 | $223K |
| Advair Hfa Fluticasone Propion/Salmeterol | 55 | 57 | 12 | $23K |
| Azelastine Hcl Generic | 55 | 66 | 23 | $909 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 53 | 62 | 15 | $5,535 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 48 | 60 | 12 | $9,116 |
| Qvar Redihaler Beclomethasone Dipropionate | 47 | 55 | 16 | $11K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 31 | 31 | 20 | $505 |
| Spiriva Respimat Tiotropium Bromide | 31 | 45 | Under 11 | $22K |
| Symbicort Budesonide/Formoterol Fumarate | 31 | 35 | 11 | $7,858 |
| Xolair Omalizumab | 29 | 29 | Under 11 | $118K |
Brand drugs: 700 claims; generic drugs: 989 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael V Keiley $1,501 ($1,501 in general payments such as food, travel and fees) from 18 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $213.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $213 |
| GlaxoSmithKline, LLC. GSK | 17 | $199 |
| CSL Behring CSL.AX | 7 | $180 |
| Genzyme Corporation SNY | 6 | $143 |
| Amgen Inc. AMGN | 6 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $107 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $105 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 3 | $65.74 |
| Grifols USA, LLC | 3 | $64.71 |
| Verona Pharma, Inc. VRNA | 2 | $54.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.